Corsaro, R.; Lombardo, R.; Ghelardini, C.; Di Cesare Mannelli, L.; Bani, D.; Bonaccorso, A.; Pignatello, R.
Development of Eudragit® Nanoparticles for Intranasal Drug Delivery: Preliminary Technological and Toxicological Evaluation. Appl. Sci. 2022, 12, 2373.
https://doi.org/10.3390/app12052373
AMA Style
Corsaro R, Lombardo R, Ghelardini C, Di Cesare Mannelli L, Bani D, Bonaccorso A, Pignatello R.
Development of Eudragit® Nanoparticles for Intranasal Drug Delivery: Preliminary Technological and Toxicological Evaluation. Applied Sciences. 2022; 12(5):2373.
https://doi.org/10.3390/app12052373
Chicago/Turabian Style
Corsaro, Roberta, Rosamaria Lombardo, Carla Ghelardini, Lorenzo Di Cesare Mannelli, Daniele Bani, Angela Bonaccorso, and Rosario Pignatello.
2022. "Development of Eudragit® Nanoparticles for Intranasal Drug Delivery: Preliminary Technological and Toxicological Evaluation" Applied Sciences 12, no. 5: 2373.
https://doi.org/10.3390/app12052373
APA Style
Corsaro, R., Lombardo, R., Ghelardini, C., Di Cesare Mannelli, L., Bani, D., Bonaccorso, A., & Pignatello, R.
(2022). Development of Eudragit® Nanoparticles for Intranasal Drug Delivery: Preliminary Technological and Toxicological Evaluation. Applied Sciences, 12(5), 2373.
https://doi.org/10.3390/app12052373